PCVX Valuation Metrics
FCF$-712.55M
FCF Growth Rate—
EPS Growth (CAGR)—
WACC10.00%
Vaxcyte Inc
Exchange: NASDAQSector: HealthcareIndustry: Biotechnology
Vaxcyte Inc
Current Price
$55.95
+0.56%Profile
Valuation (TTM)
Market Cap$7.28B
P/E-9.50
EV—
P/B2.71
Shares Out130.18M
P/Sales—
Revenue$0.00
EV/EBITDA—
Vaxcyte Inc (PCVX) Valuation
Fair Value Models
Graham Number, PEG-based, and Earnings-based models
View Fair Value →PCVX Valuation & Fair Value Analysis
Vaxcyte Inc (PCVX) valuation analysis using multiple fair value methodologies. GoodMoat calculates a blended fair value target using discounted cash flow (DCF) analysis, the Graham Number, and earnings-based valuation models.
The price-to-earnings (P/E) ratio is -9.50. Price-to-book ratio is 2.71. PEG ratio is -0.12.
GoodMoat's valuation models include the Graham Number (based on EPS and book value), an earnings-based model (discounted future EPS), and a PEG-adjusted valuation. The three models are averaged to produce a blended fair value estimate. Use these tools alongside the DCF calculator and reverse DCF to form a comprehensive view of Vaxcyte Inc's intrinsic value.